B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with Dasatinib in cutaneous T-cell lymphoma (CTCL)

D L Petersen; T Krejsgaard; J Berthelsen; S Fredholm; A Willerslev-Olsen; N A Sibbesen; C M Bonefeld; M H Andersen; C Francavilla; J V Olsen; T Hu; M Zhang; M A Wasik; C Geisler; Anders Woetmann; Niels Ødum

doi:10.1038/leu.2014.192

B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with Dasatinib in cutaneous T-cell lymphoma (CTCL)

D L Petersen, T Krejsgaard, J Berthelsen, S Fredholm, A Willerslev-Olsen, N A Sibbesen, C M Bonefeld, M H Andersen, C Francavilla, J V Olsen, T Hu, M Zhang, M A Wasik, C Geisler, Anders Woetmann, Niels Ødum

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

36 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Leukemia
Vol/bind	28
Sider (fra-til)	2109-12
Antal sider	4
ISSN	0887-6924
DOI	https://doi.org/10.1038/leu.2014.192
Status	Udgivet - 12 jun. 2014

Adgang til dokumentet

10.1038/leu.2014.192

Citationsformater

Petersen, D. L., Krejsgaard, T., Berthelsen, J., Fredholm, S., Willerslev-Olsen, A., Sibbesen, N. A., Bonefeld, C. M., Andersen, M. H., Francavilla, C., Olsen, J. V., Hu, T., Zhang, M., Wasik, M. A., Geisler, C., Woetmann, A., & Ødum, N. (2014). B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with Dasatinib in cutaneous T-cell lymphoma (CTCL). Leukemia, 28, 2109-12. https://doi.org/10.1038/leu.2014.192

B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with Dasatinib in cutaneous T-cell lymphoma (CTCL). / Petersen, D L; Krejsgaard, T; Berthelsen, J; Fredholm, S; Willerslev-Olsen, A; Sibbesen, N A; Bonefeld, C M; Andersen, M H; Francavilla, C; Olsen, J V; Hu, T; Zhang, M; Wasik, M A; Geisler, C ; Woetmann, Anders ; Ødum, Niels.

I: Leukemia, Bind 28, 12.06.2014, s. 2109-12.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Petersen, DL, Krejsgaard, T, Berthelsen, J, Fredholm, S, Willerslev-Olsen, A, Sibbesen, NA, Bonefeld, CM, Andersen, MH, Francavilla, C, Olsen, JV, Hu, T, Zhang, M, Wasik, MA, Geisler, C , Woetmann, A & Ødum, N 2014, 'B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with Dasatinib in cutaneous T-cell lymphoma (CTCL)', Leukemia, bind 28, s. 2109-12. https://doi.org/10.1038/leu.2014.192

Petersen, D L ; Krejsgaard, T ; Berthelsen, J ; Fredholm, S ; Willerslev-Olsen, A ; Sibbesen, N A ; Bonefeld, C M ; Andersen, M H ; Francavilla, C ; Olsen, J V ; Hu, T ; Zhang, M ; Wasik, M A ; Geisler, C ; Woetmann, Anders ; Ødum, Niels. / B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with Dasatinib in cutaneous T-cell lymphoma (CTCL). I: Leukemia. 2014 ; Bind 28. s. 2109-12.

@article{ab7e19dc9b1045778e926d1229d7b070,

title = "B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with Dasatinib in cutaneous T-cell lymphoma (CTCL)",

author = "Petersen, {D L} and T Krejsgaard and J Berthelsen and S Fredholm and A Willerslev-Olsen and Sibbesen, {N A} and Bonefeld, {C M} and Andersen, {M H} and C Francavilla and Olsen, {J V} and T Hu and M Zhang and Wasik, {M A} and C Geisler and Anders Woetmann and Niels {\O}dum",

year = "2014",

month = jun,

day = "12",

doi = "10.1038/leu.2014.192",

language = "English",

volume = "28",

pages = "2109--12",

journal = "Leukemia",

issn = "0887-6924",

publisher = "nature publishing group",

}

TY - JOUR

T1 - B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with Dasatinib in cutaneous T-cell lymphoma (CTCL)

AU - Petersen, D L

AU - Krejsgaard, T

AU - Berthelsen, J

AU - Fredholm, S

AU - Willerslev-Olsen, A

AU - Sibbesen, N A

AU - Bonefeld, C M

AU - Andersen, M H

AU - Francavilla, C

AU - Olsen, J V

AU - Hu, T

AU - Zhang, M

AU - Wasik, M A

AU - Geisler, C

AU - Woetmann, Anders

AU - Ødum, Niels

PY - 2014/6/12

Y1 - 2014/6/12

U2 - 10.1038/leu.2014.192

DO - 10.1038/leu.2014.192

M3 - Journal article

C2 - 24919804

VL - 28

SP - 2109

EP - 2112

JO - Leukemia

JF - Leukemia

SN - 0887-6924

ER -